Registro:

Referencias:

• (2005) Immunization Against Diseases of Public Health Importance, , http://www.who.int/mediacentre/factsheets/fs288/en/index.html, WHO World Health Organization (WHO) Accessed25Aug2010
• Doja, A., Roberts, W., Immunizations and autism: A review of the literature (2006) Canadian Journal of Neurological Sciences, 33 (4), pp. 341-346
• Chen, R.T., Pless, R., Destefano, F., Epidemiology of autoimmune reactions induced by vaccination (2001) Journal of Autoimmunity, 16 (3), pp. 309-318. , DOI 10.1006/jaut.2000.0491
• Geier, D.A., Geier, M.R., A case-control study of serious autoimmune adverse events following hepatitis B immunization (2005) Autoimmunity, 38 (4), pp. 295-301. , DOI 10.1080/08916930500144484
• Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P.A., Clarke, M., Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration (2009) BMJ, 339, p. 2700. , 19622552 10.1136/bmj.b2700
• (2010) Immunization Schedule, , http://www.cdc.gov/vaccines/recs/schedules/default.htm, CDC Center for Disease Control and Prevention of the United States of America Accessed22Aug2010
• Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses (2003) British Medical Journal, 327 (7414), pp. 557-560
• Takkouche, B., Cadarso-Suarez, C., Spiegelman, D., Evaluation of old and new tests of heterogeneity in epidemiologic meta- analysis (1999) American Journal of Epidemiology, 150 (2), pp. 206-215
• Andersen, E., Isager, H., Hyllested, K., Risk factors in multiple sclerosis: Tuberculin reactivity, age at measles infection, tonsillectomy and appendectomy (1981) Acta Neurologica Scandinavica, 63 (2), pp. 131-135
• Bansil, S., Singhal, B.S., Ahuja, G.K., Riise, T., Ladiwala, U., Behari, M., Cook, S.D., Multiple sclerosis in India: A case-control study of environmental exposures (1997) Acta Neurologica Scandinavica, 95 (2), pp. 90-95
• Berr, C., Puel, J., Clanet, M., Ruidavets, J.B., Mas, J.L., Alperovitch, A., Risk factors in multiple sclerosis: A population-based case-control study in Hautes-Pyrenees, France (1989) Acta Neurologica Scandinavica, 80 (1), pp. 46-50
• Casetta, I., Granieri, E., Malagu, S., Tola, M.R., Paolino, E., Caniatti, L.M., Govoni, V., Fainardi, E., Environmental risk factors and multiple sclerosis: A community-based, case-control study in the province of Ferrara, Italy (1994) Neuroepidemiology, 13 (3), pp. 120-128
• Pekmezovic, T., Jarebinski, M., Drulovic, J., Childhood infections as risk factors for multiple sclerosis: Belgrade case-control study (2004) Neuroepidemiology, 23 (6), pp. 285-288. , DOI 10.1159/000080094
• Zorzon, M., Zivadinov, R., Nasuelli, D., Dolfini, P., Bosco, A., Bratina, A., Tommasi, M.A., Cazzato, G., Risk factors of multiple sclerosis: A case-control study (2003) Neurological Sciences, 24 (4), pp. 242-247. , DOI 10.1007/s10072-003-0147-6
• Kurtzke, J.F., Hyllested, K., Arbuckle, J.D., Bronnum-Hansen, H., Wallin, M.T., Heltberg, A., Jacobsen, H., Eriksen, L.S., Multiple sclerosis in the Faroe Islands: 7. Results of a case control questionnaire with multiple controls (1997) Acta Neurologica Scandinavica, 96 (3), pp. 149-157
• DeStefano, F., Verstraeten, T., Jackson, L.A., Okoro, C.A., Benson, P., Black, S.B., Shinefield, H.R., Chen, R.T., Vaccinations and risk of central nervous system demyelinating diseases in adults (2003) Archives of Neurology, 60 (4), pp. 504-509. , DOI 10.1001/archneur.60.4.504
• Ascherio, A., Zhang, S.M., Hernan, M.A., Olek, M.J., Coplan, P.M., Brodovicz, K., Walker, A.M., Hepatitis B vaccination and the risk of multiple sclerosis (2001) New England Journal of Medicine, 344 (5), pp. 327-332. , DOI 10.1056/NEJM200102013440502
• Hernan, M.A., Jick, S.S., Olek, M.J., Jick, H., Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study (2004) Neurology, 63 (5), pp. 838-842
• Hocine, M.N., Farrington, C.P., Touze, E., Whitaker, H.J., Fourrier, A., Moreau, T., Tubert-Bitter, P., Hepatitis B vaccination and first central nervous system demyelinating events: Reanalysis of a case-control study using the self-controlled case series method (2007) Vaccine, 25 (31), pp. 5938-5943. , DOI 10.1016/j.vaccine.2007.05.032, PII S0264410X07005944
• Ramagopalan, S.V., Valdar, W., Dyment, D.A., Deluca, G.C., Yee, I.M., Giovannoni, G., Ebers, G.C., Group, C.C.S., Association of infectious mononucleosis with multiple sclerosis. A population-based study (2009) Neuroepidemiology, 32 (4), pp. 257-262. , 10.1159/000201564 19209005 10.1159/000201564
• Touze, E., Fourrier, A., Rue-Fenouche, C., Ronde-Oustau, V., Jeantaud, I., Begaud, B., Alperovitch, A., Hepatitis B vaccination and first central nervous system demyelinating event: A case-control study (2002) Neuroepidemiology, 21 (4), pp. 180-186. , DOI 10.1159/000059520
• Zipp, F., Weil, J.G., Einhaupl, K.M., No increase in demyelinating diseases after hepatitis B vaccination [1] (1999) Nature Medicine, 5 (9), pp. 964-965. , DOI 10.1038/12376
• Confavreux, C., Suissa, S., Saddier, P., Bourdes, V., Vukusic, S., Vaccinations and the risk of relapse in multiple sclerosis (2001) New England Journal of Medicine, 344 (5), pp. 319-326. , DOI 10.1056/NEJM200102013440501
• Bamford, C.R., Sibley, W.A., Laguna, J.F., Swine influenza vaccination in patients with multiple sclerosis (1978) Archives of Neurology, 35 (4), pp. 242-243
• Miller, A.E., Morgante, L.A., Buchwald, L.Y., Nutile, S.M., Coyle, P.K., Krupp, L.B., Doscher, C.A., Lopez, S., A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis (1997) Neurology, 48 (2), pp. 312-314
• Mokhtarian, F., Influenza virus vaccination of patients with multiple sclerosis (1997) Multiple Sclerosis, 3 (4), pp. 243-247
• Myers, L.W., Ellison, G.W., Lucia, M., Novom, S., Swine-influenza vaccination in multiple sclerosis (1976) N Engl J Med, 295 (21), p. 1204. , 790182 1:STN:280:DyaE2s%2FjsVGgtg%3D%3D
• Ahlgren, C., Torén, K., Odén, A., Andersen, O., A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk (2009) Eur J Epidemiol, 24 (9), pp. 541-552. , 10.1007/s10654-009-9367-2 19633994 10.1007/s10654-009-9367-2
• Zilber, N., Kahana, E., Risk factors for multiple sclerosis: A case-control study in Israel (1996) Acta Neurologica Scandinavica, 94 (6), pp. 395-403
• Compston, D.A.S., Vakarelis, B.N., Paul, E., Viral infection in patients with multiple sclerosis and HLA-DR matched controls (1986) Brain, 109 (2), pp. 325-344
• Alter, M., Speer, J., Clinical evaluation of possible etiologic factors in multiple sclerosis (1968) Neurology, 18 (2), pp. 109-116. , 5688752 1:STN:280:DyaF1c7itlagsA%3D%3D
• Atkins, D., Best, D., Briss, P.A., Eccles, M., Falck-Ytter, Y., Flottorp, S., Guyatt, G.H., Group, G.W., Grading quality of evidence and strength of recommendations (2004) BMJ, 328 (7454), p. 1490. , doi: 10.1136/bmj.328.7454.1490
• Weiner, H.L., The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease? (2009) Ann Neurol, 65 (3), pp. 239-248. , 10.1002/ana.21640 19334069 10.1002/ana.21640 1:CAS:528: DC%2BD1MXltVOktrg%3D
• Ramagopalan, S.V., Dobson, R., Meier, U.C., Giovannoni, G., Multiple sclerosis: Risk factors, prodromes, and potential causal pathways (2010) Lancet Neurol, 9 (7), pp. 727-739. , 10.1016/S1474-4422(10)70094-6 20610348 10.1016/S1474-4422(10)70094-6
• Baranzini, S.E., Mudge, J., Van Velkinburgh, J.C., Khankhanian, P., Khrebtukova, I., Miller, N.A., Zhang, L., Kingsmore, S.F., Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis (2010) Nature, 464 (7293), pp. 1351-1356. , 10.1038/nature08990 20428171 10.1038/nature08990 1:CAS:528: DC%2BC3cXltl2ltLw%3D
• Hernan, M.A., Olek, M.J., Ascherio, A., Geographic variation of MS incidence in two prospective studies of US women (1999) Neurology, 53 (8), pp. 1711-1718
• Munger, K.L., Zhang, S.M., O'Reilly, E., Hernan, M.A., Olek, M.J., Willett, W.C., Ascherio, A., Vitamin D intake and incidence of multiple sclerosis (2004) Neurology, 62 (1), pp. 60-65
• Hernan, M.A., Jick, S.S., Logroscino, G., Olek, M.J., Ascherio, A., Jick, H., Cigarette smoking and the progression of multiple sclerosis (2005) Brain, 128 (6), pp. 1461-1465. , DOI 10.1093/brain/awh471
• Ascherio, A., Munger, K.L., Environmental risk factors for multiple sclerosis. Part I: The role of infection (2007) Annals of Neurology, 61 (4), pp. 288-299. , DOI 10.1002/ana.21117
• Correale, J., Fiol, M., Gilmore, W., The risk of relapses in multiple sclerosis during systemic infections (2006) Neurology, 67 (4), pp. 652-659. , DOI 10.1212/01.wnl.0000233834.09743.3b, PII 0000611420060822000025
• Buljevac, D., Flach, H.Z., Hop, W.C.J., Hijdra, D., Laman, J.D., Savelkoul, H.F.J., Van Der Meche, F.G.A., Hintzen, R.Q., Prospective study on the relationship between infections and multiple sclerosis exacerbations (2002) Brain, 125 (5), pp. 952-960
• Correale, J., Farez, M., Association between parasite infection and immune responses in multiple sclerosis (2007) Annals of Neurology, 61 (2), pp. 97-108. , DOI 10.1002/ana.21067
• Hernan, M.A., Alonso, A., Hernandez-Diaz, S., Tetanus vaccination and risk of multiple sclerosis: A systematic review (2006) Neurology, 67 (2), pp. 212-215. , DOI 10.1212/01.wnl.0000225079.51201.f9, PII 0000611420060725000010
• Hill, A.B., The environment and disease: Association or causation? (1965) Proc R Soc Med, 58, pp. 295-300. , 14283879 1:STN:280:DyaF2M%2FovVCmsw%3D%3D
• Vandenbroucke, J.P., Von Elm, E., Altman, D.G., Gotzsche, P.C., Mulrow, C.D., Pocock, S.J., Poole, C., Egger, M., Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration (2007) PLoS Medicine, 4 (10), pp. 1628-1654. , http://medicine.plosjournals.org/archive/1549-1676/4/10/pdf/10. 1371_journal.pmed.0040297-S.pdf, DOI 10.1371/journal.pmed.0040297
• Lau, J., Antman, E.M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., Chalmers, T.C., Cumulative meta-analysis of therapeutic trials for myocardial infarction (1992) N Engl J Med, 327 (4), pp. 248-254. , 10.1056/NEJM199207233270406 1614465 10.1056/NEJM199207233270406 1:STN:280:DyaK38zhtVCqsg%3D%3D
• Cabrera-Gómez, J.A., Echazabal-Santana, N., García- González, L., Ramos-Cedeño, A.M., Rodríguez-Roque, M.O., López-Hernández, O., Cabrera-Núñez, J.A., Téllez, L., A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. for or against vaccination? (2002) Rev Neurol, 34 (4), pp. 358-363. , 12022053
• Chaves, M., Riccio, P., Patrucco, L., Rojas, J., Cristiano, E., Longitudinal myelitis associated with yellow fever vaccination (2009) J Neurovirol, 15 (4), pp. 348-350. , doi: 10.1080/13550280903062805
• Miller, H., Cendrowski, W., Shapira, K., Multiple sclerosis and vaccination (1967) Br Med J, 2 (5546), pp. 210-213. , 6023105 10.1136/bmj.2.5546.210 1:STN:280:DyaF2s7jsVyjuw%3D%3D
• Sutton, I., Lahoria, R., Tan, I., Clouston, P., Barnett, M., CNS demyelination and quadrivalent HPV vaccination (2009) Multiple Scler, 15 (1), pp. 116-119. , 10.1177/1352458508096868 10.1177/1352458508096868 1:STN:280: DC%2BD1M%2FhslWgsQ%3D%3D
• Terney, D., Beniczky, S., Barsi, P., Kondákor, I., Perényi, J., Faludi, B., Szapper, M., Vécsei, L., Multiple sclerosis after hepatitis B vaccination in a 16-year-old patient (2006) Chin Med J, 119 (1), pp. 77-79. , 16454987
• Wildemann, B., Jarius, S., Hartmann, M., Regula, J.U., Hametner, C., Acute disseminated encephalomyelitis following vaccination against human papilloma virus (2009) Neurology, 72 (24), pp. 2132-2133. , 10.1212/WNL.0b013e3181aa53bb 19528522 10.1212/WNL.0b013e3181aa53bb 1:STN:280:DC%2BD1MvitFOntA%3D%3D

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------